锦欣生殖医疗集团有限公司（股票代码：01951）于2026年6月12日公告，公司在香港联交所场内回购3,854,000股普通股，占已发行股本约0.14%，每股回购价介乎2.18港元至2.22港元，总耗资约845.95万港元。
截至本次回购后，公司已发行股本仍为2,705,044,043股，库藏股数为0股。公司回购股份的授权决议于2025年6月26日获通过，可回购股份总数为274,470,604股，至今已合计回购112,283,000股，占授权通过日已发行股本约4.0909%。
公司确认本次回购事宜已遵守香港联交所上市规则及相关法律程序。公告由董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.